Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a 14.177% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
(a) CC1CC(C)CN(C(=O)CCC(=O)Nc2nnc(C3CCCCC3)s2)C1
(b) CCOC(=O)C1CCN(C(=O)COc2ccc(S(=O)(=O)N3CCOCC3)cc2)CC1
(c) O=C(/C=C/c1cccc(Cl)c1)NCCN1CCOCC1
Answer: a. CC1CC(C)CN(C(=O)CCC(=O)Nc2nnc(C3CCCCC3)s2)C1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1CC(C)CN(C(=O)CCC(=O)Nc2nnc(C3CCCCC3)s2)C1
CC1CC(C)CN(C(=O)CCC(=O)Nc2nnc(C3CCCCC3)s2)C1
N-(5-cyclohexyl-1,3,4-thiadiazol-2-yl)-4-(3,5-dimethylpiperidin-1-yl)-4-oxobutanamide